Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

PURPOSE: In clinical practice, we found some of the patients who received transarterial chemoembolization (TACE) with molecular targeted agents (MTGs) plus immune checkpoint inhibitors (ICIs) for hepatocellular carcinoma (HCC) had obvious liquefactive necrosis formation within the tumor and some eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingliang, Zhou, Chen, Liu, Jiacheng, Shi, Qin, Huang, Songjiang, Yang, Chongtu, Li, Tongqiang, Chen, Yang, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434848/
https://www.ncbi.nlm.nih.gov/pubmed/34522136
http://dx.doi.org/10.2147/CMAR.S328812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434848/
https://www.ncbi.nlm.nih.gov/pubmed/34522136
http://dx.doi.org/10.2147/CMAR.S328812

Ejemplares similares